LINC00511 expression was positively linked to early BC stages (I/II), with a 2.5-fold rise relative to the primary localized advanced stage III cases, in approximately the same number of BC patients, emphasizing the importance of measuring LINC00511 for BC early diagnosis. The gene discussed is LINC00511; the disease is breast cancer.